A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)

NCT01590771 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

498

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin
DRUG: Placebo
DRUG: Gliclazide
DRUG: Glimepiride
DRUG: Metformin

Sponsor

Merck Sharp & Dohme LLC